InvestorsHub Logo
Followers 58
Posts 640
Boards Moderated 0
Alias Born 01/22/2023

Re: exwannabe post# 624576

Friday, 08/25/2023 11:32:28 AM

Friday, August 25, 2023 11:32:28 AM

Post# of 700547
I think you may have missed this, or just forgot. I am here to refresh your memory:

https://www.uclahealth.org/news/fda-approval-brain-cancer-alzheimers

FDA approvals may move UCLA brain cancer and Alzheimer’s treatments from bench to bedside



A vaccine to treat glioblastoma called DCVax-L has been in development for several years. Linda Liau, MD, PhD, MBA, and a team of UCLA researchers were the first to investigate whether a patient’s own dendritic cells (a specialized type of immune cell) could be used to create a personalized treatment for the deadly cancer.



At UCLA, Dr. Liau and other researchers are now testing whether the vaccine would be more effective in combination with a PD-1 checkpoint inhibitor. Checkpoint inhibitors are a type of immunotherapy that work by blocking proteins that stop the immune system from attacking cancer cells. While the vaccine allows T-cells to get inside of the tumor, the checkpoint inhibitors may allow T-cells to be more functional and better attack the tumor cells.



Right from the UCLA website, not second-hand information.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News